Short pages
Jump to navigation
Jump to search
Showing below up to 50 results in range #20,071 to #20,120.
- (hist) Acute viral nasopharyngitis X ray [407 bytes]
- (hist) Pituitary apoplexy primary prevention [407 bytes]
- (hist) KN motif and ankyrin repeat domains 4 [407 bytes]
- (hist) Zinc finger protein 541 [407 bytes]
- (hist) Zinc finger protein 507 [407 bytes]
- (hist) Zinc finger protein 786 [407 bytes]
- (hist) Zinc finger protein 517 [407 bytes]
- (hist) SPANX family member N5 [407 bytes]
- (hist) Mixed connective tissue disease other imaging findings [407 bytes]
- (hist) C11orf87 (gene) [407 bytes]
- (hist) Cancer/testis antigen 55 [407 bytes]
- (hist) Cryopyrin-associated periodic syndrome primary prevention [407 bytes]
- (hist) Progeria other diagnostic studies [407 bytes]
- (hist) Subependymal giant cell astrocytoma echocardiography and ultrasound [407 bytes]
- (hist) COVID-19-associated heart failure electrocardiogram [407 bytes]
- (hist) Hypoangiotensinemia [408 bytes]
- (hist) Maternal-fetal medicine [408 bytes]
- (hist) Helminth protein [408 bytes]
- (hist) Polybutylene [408 bytes]
- (hist) FFANY Shoes on Sale [408 bytes]
- (hist) Pharmaceutical Society of Northern Ireland [408 bytes]
- (hist) Swedish Sign Language [408 bytes]
- (hist) Klinični center Ljubljana [408 bytes]
- (hist) Functional symptom [408 bytes]
- (hist) Carbamoyl phosphate synthase [408 bytes]
- (hist) Fluorenylmethyloxycarbonylchloride [408 bytes]
- (hist) Meiocyte [408 bytes]
- (hist) Congenital adrenal hyperplasia CT [408 bytes]
- (hist) Congenital adrenal hyperplasia primary prevention [408 bytes]
- (hist) Congenital adrenal hyperplasia cost-effectiveness of therapy [408 bytes]
- (hist) Congenital adrenal hyperplasia future or investigational therapies [408 bytes]
- (hist) Mesothelioma cost-effectiveness of therapy [408 bytes]
- (hist) Mesothelioma future or investigational therapies [408 bytes]
- (hist) Mucoepidermoid carcinoma cost-effectiveness of therapy [408 bytes]
- (hist) Mucoepidermoid carcinoma future or investigational therapies [408 bytes]
- (hist) Pancreatic cancer cost-effectiveness of therapy [408 bytes]
- (hist) Reactive arthritis screening [408 bytes]
- (hist) Leukocytosis historical perspective [408 bytes]
- (hist) Pancreatic cancer case study one [408 bytes]
- (hist) Mallory-Weiss syndrome cost-effectiveness of therapy [408 bytes]
- (hist) Mallory-Weiss syndrome future or investigational therapies [408 bytes]
- (hist) Mallory-Weiss syndrome case study one [408 bytes]
- (hist) Proctitis differential diagnosis [408 bytes]
- (hist) Dermatofibroma secondary prevention [408 bytes]
- (hist) Renal oncocytoma screening [408 bytes]
- (hist) Hypogonadism secondary prevention [408 bytes]
- (hist) Pseudohypoparathyroidism other imaging findings [408 bytes]
- (hist) Respiratory failure other imaging findings [408 bytes]
- (hist) Post-streptococcal glomerulonephritis surgery [408 bytes]
- (hist) Foodborne illness case study one [408 bytes]